Wei Li

45PUBLICATIONS
118CO-AUTHORS
Molecular targetsMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesNonlinear optics and spectroscopy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Apr 22, 2026
QW-5-70 targets the colchicine site and demonstrates antitumor activity in P-gp-overexpressing cancer models.

|Apr 13, 2026
Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. <i>Cells</i> 2024, <i>13</i>, 239.

Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy

|Mar 11, 2026
Novel Triazoloquinoxaline-Based Tubulin Polymerization Inhibitor Induces Necroptosis and Significantly Inhibits Metastatic Melanoma Tumor Growth.

Christopher J Clark, Shelby N Waddell, Garrett E Tessmer

|Jan 28, 2026
VERU-111 Promotes an Anti-Tumor Response Through Restoration of Gut Microbial Homeostasis and Associated Metabolic Dysregulation.

Md Abdullah Al Mamun, Ahmed Rakib, Mousumi Mandal

|Dec 31, 2025
A Pyrimidine-Based Tubulin Inhibitor Shows Potent Anti-Glioblastoma Activity In Vitro and In Vivo.

Satyanarayana Pochampally, Lawrence M Pfeffer, Gustavo A Miranda-Carboni

|Dec 18, 2025
Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancer.

Rui Wang, Chun Cai, Shanshan Deng

Pageof 8

Frequent Collaborators

21 joint publications

Duane D Miller

7 joint publications

Andrzej T Slominski

6 joint publications

Sicheng Zhang

5 joint publications

Bernd Meibohm